Table 1.

Demographic and Clinical Characteristics of the Study Population

Characteristic	Number	Denominatora	% or IQR
Median age, years	39		33–45
Male sex	28980		77
Race		32142
White	13860		43
Black	12360		38
Hispanic	4735		15
Otherb	1187		4
Injection drug use as HIV risk factorc	6253	32973	19
HAART type
PI-based	21023		56
NNRTI-based	12302		33
PI + NNRTI or ≥ 3 NRTI	4520		12
Median CD4+ lymphocytes/mm3
Prior to HAARTc	207	24642	77–346
Median HIV-1 RNA (copies/mL)
Prior to HAARTc	48312	22989	6432–183677
Developed confirmed diagnosis of TB after HAART initiation	145		0.4
Died prior to 1 August 2009	4913		13

NOTE. There were 37 845 persons in the study. Data presented pertain to those persons for whom data were available. HAART, highly active antiretroviral therapy; IQR, interquartile range; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase; PI, HIV-1 protease inhibitor; TB, tuberculosis.

^aNumber of persons with available data is 37 845 unless otherwise noted.

^bIncludes American Indian, Asian, Pacific Islander, and multiracial.

^cWithin 12 months prior to HAART initiation.